NCT07136636

Brief Summary

The goal of this ambispective cohort study is to reveal the early indicators of delayed language development in children born with hypoxic-ischemic encephalopathy (HIE). We will examine the prognostic accuracy of different biomarkers, with a special focus on the ADC values of the corpus callosum. The main questions it aims to answer are:

  1. 1.To what extent does hypoxic-ischemic encephalopathy (HIE) in infancy affect intellectual development (IQ), receptive and expressive language abilities at different levels of the language system, and memory capacities related to language development?
  2. 2.What is the relationship between early biomarkers of brain injury-such as blood gas levels, lactate, aEEG, and MRI findings (Weeke scoring system, ADC values of the corpus callosum)-and long-term cognitive developmental outcomes?
  3. 3.What is the incidence of autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) in this high-risk population of infants with HIE?
  4. 4.Is there an association between the Weeke Total Score and long-term language developmental outcomes?
  5. 5.Can restricted diffusion (ADC values) of the splenium of the corpus callosum serve as an early neuroradiological marker of developmental language disorder (DLD)?

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
93

participants targeted

Target at P50-P75 for all trials

Timeline
5mo left

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress72%
Apr 2025Dec 2026

Study Start

First participant enrolled

April 1, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 14, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 22, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

August 22, 2025

Status Verified

August 1, 2025

Enrollment Period

1.7 years

First QC Date

August 14, 2025

Last Update Submit

August 14, 2025

Conditions

Keywords

HIE - Hypoxic - Ischemic Encephalopathydelayed language developmentneurodevelopmentMRIbiomarkercorpus callosum diffusion restrictionIQnewborn prediction tool

Outcome Measures

Primary Outcomes (2)

  • Cognitive abilities - WPPSI-IV

    At the age of 4-7 years

  • Language abilities - KOBAK

    At the age of 4-7 years

Secondary Outcomes (6)

  • Socioeconomic status - Socioeconomic questionnaire

    At the age of 4-7 years

  • Parental concerns - Jaworsky Questionnaire

    At the age of 4-7 years

  • Social and Communication skills - Social Communication Questionnaire

    At the age of 4-7 years

  • Digital screen use - ScreenQ

    At the age of 4-7 years

  • ADHD traits - ADHD Rating Scale

    At the age of 4-7 years

  • +1 more secondary outcomes

Study Arms (1)

Children born with Hypoxic-Ischemic Encephalopathy (HIE)

Eligibility Criteria

Age0 Years - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children with HIE

You may qualify if:

  • Born at ≥ 35th week of gestation
  • Attended follow-up examinations at two years of age
  • Has parental informed consent

You may not qualify if:

  • Hearing loss
  • Multilingual language environment
  • Congenital abnormalities
  • Metabolic disease
  • Sudden unexpected postnatal collapse
  • Brain injury not caused by HIE
  • Severe motor impairment defined as a score \<70 on the psychomotor development index (PDI) at 2 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Semmelweis University

Budapest, Hungary

RECRUITING

Related Publications (5)

  • Bartha-Doering L, Kollndorfer K, Schwartz E, Fischmeister FPS, Alexopoulos J, Langs G, Prayer D, Kasprian G, Seidl R. The role of the corpus callosum in language network connectivity in children. Dev Sci. 2021 Mar;24(2):e13031. doi: 10.1111/desc.13031. Epub 2020 Sep 1.

    PMID: 32790079BACKGROUND
  • Weeke LC, Groenendaal F, Mudigonda K, Blennow M, Lequin MH, Meiners LC, van Haastert IC, Benders MJ, Hallberg B, de Vries LS. A Novel Magnetic Resonance Imaging Score Predicts Neurodevelopmental Outcome After Perinatal Asphyxia and Therapeutic Hypothermia. J Pediatr. 2018 Jan;192:33-40.e2. doi: 10.1016/j.jpeds.2017.09.043.

    PMID: 29246356BACKGROUND
  • Ni Bhroin M, Kelly L, Sweetman D, Aslam S, O'Dea MI, Hurley T, Slevin M, Murphy J, Byrne AT, Colleran G, Molloy EJ, Bokde ALW. Relationship Between MRI Scoring Systems and Neurodevelopmental Outcome at Two Years in Infants With Neonatal Encephalopathy. Pediatr Neurol. 2022 Jan;126:35-42. doi: 10.1016/j.pediatrneurol.2021.10.005. Epub 2021 Oct 13.

    PMID: 34736061BACKGROUND
  • Chin EM, Jayakumar S, Ramos E, Gerner G, Soares BP, Cristofalo E, Leppert M, Allen M, Parkinson C, Johnston M, Northington F, Burton VJ. Preschool Language Outcomes following Perinatal Hypoxic-Ischemic Encephalopathy in the Age of Therapeutic Hypothermia. Dev Neurosci. 2019 Jun 5:1-11. doi: 10.1159/000499562. Online ahead of print.

    PMID: 31167188BACKGROUND
  • Ouwehand S, Smidt LCA, Dudink J, Benders MJNL, de Vries LS, Groenendaal F, van der Aa NE. Predictors of Outcomes in Hypoxic-Ischemic Encephalopathy following Hypothermia: A Meta-Analysis. Neonatology. 2020;117(4):411-427. doi: 10.1159/000505519. Epub 2020 Apr 1.

    PMID: 32235122BACKGROUND

MeSH Terms

Conditions

Language Development DisordersAutistic DisorderAttention Deficit Disorder with HyperactivitySpecific Language DisorderIntellectual Disability

Condition Hierarchy (Ancestors)

Language DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsAutism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersAttention Deficit and Disruptive Behavior DisordersLearning Disabilities

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
7 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 14, 2025

First Posted

August 22, 2025

Study Start

April 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

August 22, 2025

Record last verified: 2025-08

Locations